Jones Financial Companies
CTSO icon

Jones Financial Companies’s Cytosorbents Corp CTSO Stock Holding History

Jones Financial Companies’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55 Hold
93
– – ﹤0.01% 4667
2025
Q4 		$59 Sell
93
-500
-84% -$385 ﹤0.01% 4335
2025
Q3 		$553 Buy
+593
New +$584 ﹤0.01% 4027

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Jones Financial Companies's CTSO Position: Q1 2026 in Review

Jones Financial Companies held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 93 shares worth $55. The position accounts for ﹤0.01% of the portfolio, ranked #4667.

Jones Financial Companies first reported a position in CTSO in Q3 2025 and has held it in 3 quarters since. The position peaked at $553 in Q3 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • Jones Financial Companies held 93 shares of Cytosorbents Corp worth $55 as of Q1 2026.
  • Jones Financial Companies left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #4667 holding.
  • Jones Financial Companies first reported a position in Cytosorbents Corp in Q3 2025 and has held it in 3 quarters since.
  • Jones Financial Companies's Cytosorbents Corp position peaked at $553 in Q3 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.